We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Publication Shows Cancer Biomarker Identification in Formalin-Fixed Tissue
News

Publication Shows Cancer Biomarker Identification in Formalin-Fixed Tissue

Publication Shows Cancer Biomarker Identification in Formalin-Fixed Tissue
News

Publication Shows Cancer Biomarker Identification in Formalin-Fixed Tissue

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Publication Shows Cancer Biomarker Identification in Formalin-Fixed Tissue "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Expression Pathology Inc. has announced that an article in the November issue of Molecular and Cellular Proteomics has reported feasibility of cancer biomarker detection in formalin-fixed paraffin-embedded (FFPE) tissue using mass spectrometry.

The article, Proteomic Analysis of Formalin Fixed Prostate Cancer Tissue by Brian L. Hood, SAIC-Frederick, Inc./National Cancer Institute, et al., describes LC MS/MS mass spectrometry analysis of FFPE prostate cancer tissue processed by EPI’s Liquid Tissue MS Kit that identified over 1,000 proteins in histologically distinct micro-dissected regions. 

A broad range of known and recently discovered protein biomarkers of prostate cancer and hyperplasia were shown to be identified.

The methodology described in the article enables the power of mass spectrometry to be applied to vast archives of FFPE tissues and to accurately correlate protein expression to histological information and clinical outcomes in a broad range of disease conditions. 

Advertisement